Skip to main content
. 2006 Sep;55(9):1233–1239. doi: 10.1136/gut.2005.086777

Table 2 Patient characteristics by treatment group.

MPEC (n = 16) APC (n = 19) p Value
Age (y) 60 (42–68) 65 (32–84) 0.18
BO length (cm) median(range) 3 (2–6) 4 (2–6) 0.52
Hiatal hernia size (cm) (median (range)) 3 (0–6) 3 (1–5) 0.44
24 hour pH monitoring
 Total time pH <4 (%) (median (range)) 0.6 (0–29.9) 0.6 (0–23.9) 0.90
 Supine time pH <4 (%) (median (range)) 0 (0–39.6) 0.05 (0–47.2) 0.51
 Upright time pH <4 (%) (median (range)) 0.95 (0–47.9) 0.65 (0–15.8) 0.57
Maintenance PPI dose (mg) (median (range)) 20 (20–60) 40 (20–80) 0.27
No of endoscopic treatments (median (range)) 4 (2–6) 3 (2–6) 0.76
No of patients with BO reversal (%) 12 (75.0) 12 (63.1) 0.49
 (endoscopic and histological ablation)

BO, Barrett's oesophagus, PPI, proton pump inhibitor.